Jazz Pharmaceuticals Announces First Quarter 2026 Financial Results
Go back to Jazz Pharmaceuticals Announces First Quarter 2026 Financial Results| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 227.80 +1.88 (0.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $225.92 | 52 Week High | $160.00 | |||
| Open | $225.27 | 52 Week Low | $95.80 | |||
| Day High | $228.51 | P/E | 42.34 | |||
| Day Low | $222.93 | EPS | $5.38 | |||
| Volume | 386,202 | |||||
